A new study on Civil War prisoners adds to the evidence suggesting that our parents’—and even grandparents’—experiences might affect our DNA.
In California, a commitment to evidence-based care may be delaying treatment for criminal offenders.
The fall of a prominent behavioral scientist tells of a system where research is judged not on merit, but on the attention it gets.
Microchip implants are going from tech-geek novelty to genuine health tool—and you might be running out of good reasons to say no.
Overdoses in public bathrooms are turning baristas and other service workers into unwitting first responders.
A study in mice hints at a new approach for thwarting neurodegenerative diseases—but many questions remain.
Certain ingredients are pushing people of color away from good skin care.
“Memory towns” promise to provide an aging population with dementia therapy and the accessible spaces of a bygone era.
Infants spend twice as much time in REM sleep as adults—but experts still know little about what happens in their brains during those hours.
A legendary Kenyan marathoner has once again redefined what humans are capable of.
Human drugs have been crucial to poultry farming. So what’s replacing them?
Apple’s new watch can screen for heart problems. But doctors are increasingly worried about the dangers of testing healthy people for disease.
The “tour de force” technique is supercharging the search for dangerous genetic variants.
Climate change is going to revolutionize politics in cities across the world.
A favorite anecdote about the origins of the vibrator is probably a myth.
One hundred supposedly sick passengers ended up being only 19. But the story tapped into potent fears about flying.
Dermatologists are cautiously optimistic that a new vaccine could work better than so many other flawed treatments.
A recent poll suggests many doctors aren’t warning elderly patients of the risks when prescribing painkillers.
A contentious study suggests that social movements shoot themselves in the foot when they embrace a wide range of adherents.
The CDC found that reported cases of three STDs hit an all-time high in 2017, suggesting that while sexual activity is decreasing in the U.S., it’s getting riskier.
Funding cuts are one hurdle to stopping the spread of gonorrhea, syphilis, and chlamydia.